These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects. Haggman DL, Maloney JD, Morant VA, Castle LW, King-Rankine M, Goormastic M. Cleve Clin Q; 1986; 53(2):171-9. PubMed ID: 2874902 [No Abstract] [Full Text] [Related]
3. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies. Flaker GC, Madigan NP, Alpert MA, Moser SA. Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711 [Abstract] [Full Text] [Related]
4. [Antiarrhythmic action of intravenous mexiletine]. Rizzo A, Fiorilli R, Sisto F, Lisanti P. Cardiologia; 1984 Sep; 29(3-4):211-8. PubMed ID: 6541940 [No Abstract] [Full Text] [Related]
5. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. Poole JE, Werner JA, Bardy GH, Graham EL, Pulaski WP, Fahrenbruch CE, Greene HL. Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884 [Abstract] [Full Text] [Related]
6. Mexiletine for ventricular arrhythmias. Podrid PJ, Lown B. Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850 [No Abstract] [Full Text] [Related]
8. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial. Singh JB, Rasul AM, Shah A, Adams E, Flessas A, Kocot SL. Am J Cardiol; 1984 Jan 01; 53(1):84-7. PubMed ID: 6362388 [Abstract] [Full Text] [Related]
11. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation. Kim SG, Felder SD, Waspe LE, Fisher JD. Am J Cardiol; 1986 Sep 01; 58(6):485-90. PubMed ID: 3529910 [Abstract] [Full Text] [Related]
15. Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Talbot RG, Nimmo J, Julian DG, Clark RA, Neilson JM, Prescott LF. Lancet; 1973 Aug 25; 2(7826):399-404. PubMed ID: 4124889 [No Abstract] [Full Text] [Related]
16. Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias. Jelinek MV, Lohrbauer L, Lown B. Circulation; 1974 Apr 25; 49(4):659-66. PubMed ID: 4817707 [No Abstract] [Full Text] [Related]
17. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN. Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166 [Abstract] [Full Text] [Related]
18. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Campbell NP, Kelly JG, Shanks RG, Chaturvedi NC, Strong JE, Pantridge JF. Lancet; 1973 Aug 25; 2(7826):404-7. PubMed ID: 4124890 [No Abstract] [Full Text] [Related]
19. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias. Giardina EG, Wechsler ME. J Am Coll Cardiol; 1990 Apr 25; 15(5):1138-45. PubMed ID: 2179362 [Abstract] [Full Text] [Related]